Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphoscintigraphy in gynecologic malignancies.

W D Bloomer

    Seminars in Nuclear Medicine
    |January 1, 1983
    PubMed
    Summary

    Lymphoscintigraphy can detect early cancer spread in the diaphragm and lymph nodes. However, its accuracy is insufficient for routine use in diagnosing gynecologic cancers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.

    British journal of cancer·2010
    Same author

    Interaction of strong DNA-intercalating bioreductive compounds with topoisomerases I and II.

    Oncology research·2007
    Same author

    Synergistic interaction between cyclophosphamide or paclitaxel and the bioreductive compound NLCPQ-1, in vivo.

    Oncology research·2003
    Same author

    Therapeutic advantage from combining 5-fluorouracil with the hypoxia-selective cytotoxin NLCQ-1 in vivo; comparison with tirapazamine.

    Cancer chemotherapy and pharmacology·2002
    Same author

    Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia.

    International journal of cancer·2001
    Same author

    In vitro evaluation of 4-[3-(2-nitro-1-imidazolyl)-propylamino]-7-trifluoromethylquinoline hydrochloride (NLTQ-1), a new bioreductive agent as a hypoxia marker by 19F-magnetic resonance spectroscopy (19F-MRS).

    In vivo (Athens, Greece)·2001

    Area of Science:

    • Oncology
    • Diagnostic Imaging
    • Nuclear Medicine

    Background:

    • Gynecologic malignancies present diagnostic challenges, particularly in detecting early spread.
    • Conventional imaging methods like lymphangiography, ultrasound, and CT have limitations in visualizing certain lymph node abnormalities.
    • Ascitic tumor cells and diaphragmatic involvement require sensitive detection methods.

    Purpose of the Study:

    • To evaluate the utility of lymphoscintigraphy in diagnosing gynecologic malignancies.
    • To assess the potential of lymphoscintigraphy in detecting early tumor spread.
    • To compare lymphoscintigraphy with other imaging modalities for lymph node assessment.

    Main Methods:

    • Lymphoscintigraphy was performed as a noninvasive diagnostic procedure.
    • The study focused on assessing the detection of ascitic tumor cells and diaphragmatic involvement.
    • Abnormalities in lymph nodes not visualized by other methods were evaluated.

    Main Results:

    • Lymphoscintigraphy demonstrated potential in detecting small numbers of ascitic tumor cells.
    • Early diaphragmatic tumor involvement was identified using this technique.
    • It effectively delineated lymph node abnormalities missed by conventional imaging.

    Conclusions:

    • Lymphoscintigraphy is a valuable adjunctive tool for investigating gynecologic cancers.
    • The procedure shows promise for detecting early metastatic spread.
    • Current data suggest insufficient sensitivity and specificity for its routine clinical application.

    Related Experiment Videos